| UHC Commercial Medical & Drug | Surgery of the Ankle – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC Commercial Medical & Drug | Surgical and Ablative Procedures for Venous Insufficiency and Varicose Veins – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC Commercial Medical & Drug | Transcatheter Procedures for Heart Valve Conditions – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC Commercial Medical & Drug | Umbilical Cord Blood Harvesting and Storage for Future Use – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC Commercial Medical & Drug | Ustekinumab – Commercial Medical Benefit Drug Policy | 2026-07-01 |
| UHC Commercial Medical & Drug | Whole Exome and Whole Genome Sequencing (Non-Oncology Conditions) – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC Surest Medical and Drug | Itvisma® (Onasemnogene Abeparvovec-Brve) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-07-01 |
| UHC UMR Medical and Drug | Itvisma® (Onasemnogene Abeparvovec-Brve) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-07-01 |
| UHC Commercial Medical & Drug | Itvisma® (Onasemnogene Abeparvovec-Brve) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-07-01 |
| Anthem Blue Cross | Electric Tumor Treatment Field (TTF) Therapy | 2026-07-01 |